We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$70.2M
2
ARRY
Array Biopharma Inc
ARRY
+$45.8M
3
BIIB icon
Biogen
BIIB
+$43.3M
4
META icon
Meta Platforms (Facebook)
META
+$24.8M
5
AMGN icon
Amgen
AMGN
+$21.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SKT icon
776
Tanger
SKT
$4.82B
– –
-22,000
Closed -$355K
SLGN icon
777
Silgan Holdings
SLGN
$4.91B
– –
-15,000
Closed -$457K
SON icon
778
Sonoco
SON
$5.76B
– –
-7,000
Closed -$455K
SONY icon
779
Sony
SONY
$123B
– –
-170
Closed -$1.78M
SPY icon
780
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
– –
-965
Closed -$443K
TCOM icon
781
Trip.com Group
TCOM
$27.5B
– –
-43,245
Closed -$1.59M
TDG icon
782
TransDigm Group
TDG
$69.2B
– –
-4,323
Closed -$2.08M
TEF
783
DELISTED
Telefonica
TEF
– –
-314
Closed -$2.11M
TEL icon
784
TE Connectivity
TEL
$58.8B
– –
-27
Closed -$2.59M
TFC icon
785
Truist Financial
TFC
$63.2B
– –
-70,632
Closed -$3.46M
TGTX icon
786
TG Therapeutics
TGTX
$8.58B
– –
-692,000
Closed -$5.96M
THG icon
787
Hanover Insurance
THG
$7.63B
– –
-4,000
Closed -$511K
THS
788
DELISTED
Treehouse Foods
THS
– –
-11,000
Closed -$592K
TM icon
789
Toyota
TM
$210B
– –
-38
Closed -$4.71M
TTE icon
790
TotalEnergies
TTE
$193B
– –
-61
Closed -$3.4M
UAA icon
791
Under Armour
UAA
$3B
– –
-24,813
Closed -$626K
WBD icon
792
Warner Bros
WBD
$64.6B
– –
-41,724
Closed -$1.27M
WH icon
793
Wyndham Hotels & Resorts
WH
$5.46B
– –
-3,926
Closed -$218K
WIT icon
794
Wipro
WIT
$18.5B
– –
-231,364
Closed -$499K
GAP
795
The Gap Inc
GAP
$6.84B
– –
-92,028
Closed -$1.65M
EGRX
796
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-16,000
Closed -$887K
IMGN
797
DELISTED
Immunogen Inc
IMGN
– –
-579,210
Closed -$1.25M
MNDT
798
DELISTED
Mandiant, Inc. Common Stock
MNDT
– –
-22,500
Closed -$332K
CALA
799
DELISTED
Calithera Biosciences, Inc
CALA
– –
-9,000
Closed -$699K
WRI
800
DELISTED
Weingarten Realty Investors
WRI
– –
-18,000
Closed -$491K
30 31
32
33 34

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.